Published in Muscle Nerve on August 25, 1980
Reference ranges for serum C4 concentrations in subjects with and without C4 null alleles. J Clin Pathol (1986) 0.96
Antibodies to polyadenylic acid in patients with myasthenia gravis. Clin Exp Immunol (1981) 0.80
Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet (2002) 5.48
Nomenclature for the major histocompatibility complexes of different species: a proposal. Immunogenetics (1990) 3.53
Statement on the nomenclature of human C4 allotypes. Immunobiology (1983) 2.66
Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression. N Engl J Med (1973) 2.25
Disease associations with complotypes, supratypes and haplotypes. Immunol Rev (1983) 1.87
Central MHC genes, IgA deficiency and autoimmune disease. Immunol Today (1990) 1.81
Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. Transplantation (1999) 1.81
The P5 multicopy gene family in the MHC is related in sequence to human endogenous retroviruses HERV-L and HERV-16. Immunogenetics (1999) 1.71
Experimental myositis associated with hypersensitivity to muscle. J Pathol Bacteriol (1965) 1.59
Ancestral haplotypes: conserved population MHC haplotypes. Hum Immunol (1992) 1.48
Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun (2005) 1.47
Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol (1993) 1.39
Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia. Clin Exp Immunol (1975) 1.38
Laboratory tests in clinical immunology: a critique. Am J Med (1980) 1.34
Autoimmunity in ocular and generalised myasthenia gravis. J Neuroimmunol (1981) 1.32
An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics (1992) 1.32
The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. Tissue Antigens (2004) 1.31
The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster. Immunogenetics (2000) 1.29
Antibodies to skeletal muscle demonstrated by immunofluorescence in experimental autoallergic myositis. Clin Exp Immunol (1971) 1.28
Complement allotyping in SLE: association with C4A null. Aust N Z J Med (1983) 1.24
SNP profile within the human major histocompatibility complex reveals an extreme and interrupted level of nucleotide diversity. Genome Res (2000) 1.24
Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes. Immunogenetics (1986) 1.23
Genetic control of suppressor lymphocyte function in myasthenia gravis: relationship of impaired suppressor function to HLA-B8/DRW3 and cold reactive lymphocytotoxic antibodies. Clin Immunol Immunopathol (1979) 1.23
Observer variation in grading sacroiliac radiographs in HLA-B27 positive individuals. J Rheumatol (1983) 1.23
Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS (1992) 1.20
HLA and complement allotypes in Type 1 (insulin-dependent) diabetes. Diabetologia (1983) 1.20
Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: ancestral haplotypes encode particular NK-defined haplotypes. J Exp Med (1993) 1.18
Immune function in ankylosing spondylitis: apparent relationship between streptococcal responses and HLA B27. J Rheumatol Suppl (1977) 1.17
Extensive nucleotide variability within a 370 kb sequence from the central region of the major histocompatibility complex. Gene (1999) 1.12
Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM. Immunogenetics (1992) 1.11
An analysis of variation in the long-range genomic organization of the human major histocompatibility complex class II region by pulsed-field gel electrophoresis. Genomics (1989) 1.11
Cancer in connective tissue disease. Arthritis Rheum (1982) 1.11
Exposure to blood borne infections in health care workers. Med J Aust (1992) 1.10
Use of the B27 test in the diagnosis of ankylosing spondylitis: a statistical evaluation. Arthritis Rheum (1981) 1.08
A new polymorphic and multicopy MHC gene family related to nonmammalian class I. Immunogenetics (1994) 1.07
Family studies of IgA deficiency. Immunogenetics (1985) 1.07
Hepatocellular carcinoma: presentation with vertebral metastases and radicular compression. Cancer (1972) 1.07
The diagnostic significance of autoantibodies to the acetylcholine receptor. J Neuroimmunol (1982) 1.05
Diagnostic significance of thyroid microsomal antibodies in randomly selected population. Lancet (1980) 1.05
HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis. Br Med J (Clin Res Ed) (1983) 1.04
Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods (1988) 1.04
Quality assessment program for genotypic antiretroviral testing improves detection of drug resistance mutations. J Clin Microbiol (2003) 1.04
Detection of KIR2DL4 alleles by sequencing and SSCP reveals a common allele with a shortened cytoplasmic tail. Tissue Antigens (2000) 1.03
A multicenter international evaluation of single-tube amplification protocols for sequencing-based typing of HLA-DRB1 and HLA-DRB3,4,5. Tissue Antigens (2004) 1.02
Some disease-associated ancestral haplotypes carry a polymorphism of TNF. Hum Immunol (1989) 1.00
Extensive deletions and insertions in different MHC supratypes detected by pusled field gel electrophoresis. J Exp Med (1988) 0.99
Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations. Hum Immunol (1990) 0.99
Autoantibodies and HLA antigens in ocular, generalized and penicillamine-induced myasthenia gravis. Ann N Y Acad Sci (1981) 0.99
Different evolutionary histories in two subgenomic regions of the major histocompatibility complex. Genome Res (1999) 0.99
Cross-reactivity of anti-acetylcholine receptor autoantibodies. Muscle Nerve (1981) 0.98
Immune function in ankylosing spondylitics and their relatives: influence of disease and HLA B27. Clin Exp Immunol (1978) 0.98
Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants. Tissue Antigens (2005) 0.98
Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies. Am J Med (1977) 0.98
Characterisation of immunofluorescent heterophile antibodies which may be confused with autoantibodies. J Clin Pathol (1977) 0.97
Reference ranges for serum C4 concentrations in subjects with and without C4 null alleles. J Clin Pathol (1986) 0.96
Differences in gene copy number carried by different MHC ancestral haplotypes. Quantitation after physical separation of haplotypes by pulsed field gel electrophoresis. J Exp Med (1990) 0.96
Positive allergy prick tests associated with bronchial histamine responsiveness in an unselected population. J Allergy Clin Immunol (1986) 0.96
Direct observation of the gene organization of the complement C4 and 21-hydroxylase loci by pulsed field gel electrophoresis. J Exp Med (1989) 0.95
DR-positive maternal engrafted T cells in a severe combined immunodeficiency patient without graft-versus-host disease. Transplantation (1980) 0.95
MICA, MICB, and MHC beta block matching in bone marrow transplantation: relevance to transplantation outcome. Hum Immunol (2006) 0.95
The implications of intergenic polymorphism for major histocompatibility complex evolution. Genetics (2000) 0.95
Epidemiology of late presentation of HIV infection in Western Australia. Med J Aust (1992) 0.95
Maternal KIR repertoire is not associated with recurrent spontaneous abortion. Hum Reprod (2004) 0.95
Coevolution of PERB11 (MIC) and HLA class I genes with HERV-16 and retroelements by extended genomic duplication. J Mol Evol (1999) 0.95
HLA in systemic lupus erythematosus: influence on severity. Tissue Antigens (1978) 0.94
Cytotoxic effect of antisera on 51Cr-labelled monolayers of skeletal muscle. J Pathol (1973) 0.93
The major histocompatability complex (MHC) contains conserved polymorphic genomic sequences that are shuffled by recombination to form ethnic-specific haplotypes. J Mol Evol (1997) 0.93
Angioimmunoblastic lymphadenopathy with dysproteinemia. Cancer (1977) 0.93
Letter: Penicillamine therapy, antistriational antibody, and myasthenia gravis. Br Med J (1975) 0.92
Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles. Immunogenetics (1985) 0.92
Myogenesis in vitro as demonstrated by immunofluorescent staining with antimuscle serum. Exp Cell Res (1971) 0.92
Major histocompatibility complex (MHC) complement deficiency, ancestral haplotypes and systemic lupus erythematosus (SLE): C4 deficiency explains some but not all of the influence of the MHC. J Rheumatol (1991) 0.92
Vacuolar myopathy associated with chloroquine, lupus erythematosus and thymoma. Report of a case with unusual mitochondrial changes and lipid accumulation in muscle. J Neurol Sci (1977) 0.91
Antinuclear antibody. Precise and accurate quantitation without serial dilution. J Immunol Methods (1986) 0.90
Immunoglobulin deposition in liver of patients with active chronic hepatitis and antibody against smooth muscle. Br Med J (1973) 0.90
C4 allotyping on plasma or serum: application to routine laboratories. Hum Immunol (1988) 0.90
Immunological assessment of mice with chronic jaundice and runting induced by reovirus 3. Br J Exp Pathol (1973) 0.90
Haplotypic polymorphisms of the TNFB gene. Immunogenetics (1991) 0.90
Genomic organization of a polymorphic duplicated region centromeric of HLA-B. Immunogenetics (1992) 0.89
Comparison between two human endogenous retrovirus (HERV)-rich regions within the major histocompatibility complex. J Mol Evol (1999) 0.88
Polymyositis and myasthenia gravis: immunodeficiency disorders involving skeletal muscle. Lancet (1975) 0.88
The evolution of MHC diversity by segmental duplication and transposition of retroelements. J Mol Evol (1997) 0.88
Allelic and interlocus comparison of the PERB11 multigene family in the MHC. Immunogenetics (1997) 0.88
The reactivity of the antistriational antibodies associated with thymoma and myasthenia gravis. Clin Exp Immunol (1977) 0.88
Joint report of the Third International Bovine Lymphocyte Antigen (BoLA) Workshop, Helsinki, Finland, 27 July 1986. Anim Genet (1989) 0.88